Valoración del riesgo cardiovascular en la fase longitudinal del estudio Mediterránea

The equation for the FAS scale was adjusted for Spanish AHT/HC patients. Prognostic factors and SC were calculated. Benefitbetween TC and decrease of CVR in HC patients was quantified.